Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

New Molecular Trigger Described for Hypertension, Diabetes

Out-of-control enzymes do damage in both conditions, study finds

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Addison's Disease
Alzheimer's Disease
Aneurysms
Angina Pectoris
More...

Related Healthscout Videos
 border=
Importance of Good Nutrition
Controlling Incontinence
Preventing Heart Disease the Easy Way
Lifestyle Changes for Heart Disease Prevention and Treatment
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Animation: What is Hypertension?
Coronary Bypass Surgery
More...

Related Drug Information
 border=
Accupril
Actonel
Actos
Altace
More...

Related News Articles
 border=
Gender Defines Activity for Kids, Elders
'Snowbirds' Beware the Climate Changes
Family History of Aneurysm Raises Stroke Risk for Smokers
9 Genes Are Linked to Alzheimer's
More...

MONDAY, June 30 (HealthDay News) -- A newly discovered molecular malfunction may explain the development of high blood pressure, diabetes and immune problems, researchers report.

Rogue versions of enzymes known as proteases roam the body, clipping off working segments of the receptors that allow insulin to enter cells and do its job, according to a report in the June 30 online issue of Hypertension.

Text Continues Below



That uncontrolled enzymatic activity also reduces the immune system's response to infection and raises blood pressure, the report noted.

"We are describing a new mechanism for disease and injury to the body," said study author Frank DeLano, a research scientist with the department of bioengineering at the University of California, San Diego. "It is an idea that hasn't been presented before. If we apply a protease inhibitor, we can prevent the damage we see in laboratory animals."

DeLano and his collaborator, Geert Schmid-Schonbein, a professor of bioengineering at UCSD, have been working with a widely used laboratory model of disease, a rat bred to have high blood pressure.

They have found that proteases, whose function is to clear away molecular debris, can go awry and split apart a number of different cell wall receptors. If insulin receptors are damaged, normal metabolism of glucose is not possible, and diabetes can be the result. Proteases can also damage receptors that are vital for the functioning of infection-fighting leukocytes.

The researchers also found that protein receptors on the surface of cells are clipped off as the rats develop high blood pressure. "Many receptors in blood vessels cause them to relax," DeLano said. "Many proteases we see in the animals cleave receptors responsible for relaxation." Giving the rats doxycycline, an antibiotic that is also a protease inhibitor, brought down their blood pressure and restored normal immune system function.

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 6/30/2008

Related Links
 border=
From Healthscout's partner site on heart disease, MyHeartCentral.com
Learn about heart disease symptoms.
Get more information on heart disease treatment for your health!
What can you do to prevent heart disease? Prevention details here.





SOURCES: Frank DeLano, Ph.D, research scientist, department of bioengineering, University of California, San Diego; H. Glenn Bohlen, Ph.D, professor, cellular and integrative physiology, Indiana University, Indianapolis; June 30, 2008, Hypertension, online


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service    

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.